References
- US Department of Health and Human Services2012 National Survey on Drug Use and Health: Summary of National FindingsWashington, DCUS Department of Health and Human Services Available from: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.pdfAccessed August 19, 2015
- Substance Abuse and Mental Health Services AdministrationDrug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department VisitsRockville, MDSubstance Abuse and Mental Health Services Administration2013 Available from: http://www.Samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htmAccessed August 19, 2015
- PierceMBirdSMHickmanMMillarTNational record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005–2009Drug Alcohol Depend2015146172325454405
- MaugerSFraserRGillKUtilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependenceNeuropsychiatr Dis Treat20141058759824741316
- US Department of Health and Human Services Substance Abuse and Mental Health Services Administration. Center for Substance Abuse TreatmentDetoxification and Substance Abuse Treatment Training Manual – Based on a Treatment Improvement Protocol (TIP) Series 45DHHS Publication No (SMA) 08-4331Rockville, MDUS Department of Health and Human Services2008 Available from: http://162.99.3.213/products/trainingcurriculums/tip45.htmlAccessed August 19, 2015
- FiellinDAO’ConnorPGOffice-based treatment of opioid-dependent patientsN Engl J Med200234781782312226153
- MaxwellJCMcCance-KatzEFIndicators of buprenorphine and methadone use and abuse: what do we know?Am J Addict201019738820132124
- ClarkRESamnalievMBaxterJDLeungGYThe evidence doesn’t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphineHealth Aff (Millwood)2011301425143321821560
- ComerSDSullivanMAWhittingtonRAVosburgSKKowalczykWJAbuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusersNeuropsychopharmacology2008331179119117581533
- FudalaPJBridgeTPHerbertSOffice-based treatment of opiate addiction with a sublingual tablet formulation of buprenorphine and naloxoneN Engl J Med200334994995812954743
- SullivanJGWebsterLNovel buccal film formulation of buprenorphine-naloxone for the maintenance treatment of opioid dependence: a 12-week conversion studyClin Ther2015371064107525823919
- American Society of AnesthesiologistsPhysical Status Classification SystemSchaumburg, ILAmerican Society of Anesthesiologists Available from: http://www.asahq.org/resources/clinical-information/asa-physical-status-classification-systemAccessed August 19, 2015
- TompkinsDABigelowGEHarrisonJAJohnsonREFudalaPJStrainECConcurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrumentDrug Alcohol Depend200910515415919647958
- World Medical AssociationDeclaration of Helsinki (2008)Ferney-Voltaire, FranceWorld Medical Association Available from: http://www.wma.net/en/30publications/10policies/b3/index.htmlAccessed August 19, 2015
- MoreanMEde WitHKingACSofuogluMRuegerSYO’MalleySSThe drug effects questionnaire: psychometric support across three drug typesPsychopharmacology (Berl)201322717719223271193
- WalshSLPrestonKLStitzerMLConeEJBigelowGEClinical pharmacology of buprenorphine: ceiling effects at high dosesClin Pharmacol Ther1994555695808181201
- WalshSLPrestonKLBigelowGEStitzerMLAcute administration of buprenorphine in humans: Partial agonist and blockade effectsJ Pharmacol Exp Ther19952743613727542336
- PrestonKLBigelowGELiebsonIABuprenorphine and naloxone and in combination in opioid dependent humansPsychopharmacology1988944844902453895
- StrainECPrestonKLLiebsonIABigelowGEAcute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteersJ Pharmacol Exp Ther19922619859931376362
- RosadoJWalshSLBigelowGEStrainECSublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100 mg of daily methadoneDrug Alcohol Depend20079026126917517480